Literature DB >> 22850559

A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.

Michelle Healy-Stoffel1, S Omar Ahmad, John A Stanford, Beth Levant.   

Abstract

Neurotoxic lesions of the nigrostriatal pathway model the deficits found in Parkinson's disease. This study used stereology and a novel staining method to examine the effects of a partial unilateral striatal 6-hydroxydopamine (6-OHDA) lesion on substantia nigra pars compacta (SNpc) dopamine neuron number and morphology in rats. Adult male Long-Evans rats were subjected to unilateral lesion of the SNpc by intrastriatal microinjection of 6-OHDA (12.5 μg). Lesions were verified by d-amphetamine-stimulated rotation (2.5 mg/kg, sc) by force-plate rotometry 7 days post-surgery. Seven days after rotation testing, rats were euthanized, and brains were prepared for either histology (n=12) or determination of striatal dopamine content by HPLC-EC (n=20). Brains prepared for histology were stained for tyrosine hydroxylase (TH) combined with a silver nucleolar (AgNOR) stain using a modified protocol developed for stereological assessment. The AgNOR counterstain allowed for precise definition of the nucleolus of the cells, facilitating both counting and qualitative morphometry of TH-positive neurons. Stereological quantitation determined a 54% decrease in TH-positive neuron number (P<0.01), and a 14% decrease in neuron volume (P<0.05) on the lesioned side. Striatal dopamine concentration was decreased by 92% (P<0.01), suggesting that striatal dopamine analysis may overestimate the numbers of SNpc neurons lost. These findings demonstrate that combined use of TH and AgNOR staining provides improved characterization of 6-OHDA-induced pathology. Furthermore, the data suggest that decreased neuronal volume as well as number contributes to the functional deficits observed after unilateral intrastriatal 6-OHDA lesion.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850559      PMCID: PMC3443281          DOI: 10.1016/j.jneumeth.2012.07.013

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  35 in total

Review 1.  Histological changes of the dopaminergic nigrostriatal system in aging.

Authors:  A K Stark; B Pakkenberg
Journal:  Cell Tissue Res       Date:  2004-09-08       Impact factor: 5.249

Review 2.  Parkinson's disease.

Authors:  C D Marsden
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

Review 3.  The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.

Authors:  H J Gundersen; P Bagger; T F Bendtsen; S M Evans; L Korbo; N Marcussen; A Møller; K Nielsen; J R Nyengaard; B Pakkenberg
Journal:  APMIS       Date:  1988-10       Impact factor: 3.205

4.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

Authors:  U Ungerstedt; G W Arbuthnott
Journal:  Brain Res       Date:  1970-12-18       Impact factor: 3.252

Review 5.  New stereological methods for counting neurons.

Authors:  M J West
Journal:  Neurobiol Aging       Date:  1993 Jul-Aug       Impact factor: 4.673

6.  The unbiased estimation of number and sizes of arbitrary particles using the disector.

Authors:  D C Sterio
Journal:  J Microsc       Date:  1984-05       Impact factor: 1.758

7.  Aetiology of Parkinson's disease.

Authors:  D B Calne; J W Langston
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

8.  Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection.

Authors:  C D Kilts; G R Breese; R B Mailman
Journal:  J Chromatogr       Date:  1981-10-09

9.  Increase in dopamine metabolites in rat brain by neurotensin.

Authors:  E Widerlöv; C D Kilts; R B Mailman; C B Nemeroff; T J Mc Cown; A J Prange; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1982-10       Impact factor: 4.030

10.  Metabolism of amphetamine after acute and chronic administration to the rat.

Authors:  C M Kuhn; S M Schanberg
Journal:  J Pharmacol Exp Ther       Date:  1978-11       Impact factor: 4.030

View more
  13 in total

1.  Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat.

Authors:  Michelle Healy-Stoffel; S Omar Ahmad; John A Stanford; Beth Levant
Journal:  Brain Res       Date:  2014-06-09       Impact factor: 3.252

Review 2.  Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.

Authors:  Mohamed El-Gamal; Mohamed Salama; Lyndsey E Collins-Praino; Irina Baetu; Ahmed M Fathalla; Amira M Soliman; Wael Mohamed; Ahmed A Moustafa
Journal:  Neurotox Res       Date:  2021-03-25       Impact factor: 3.911

3.  Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum.

Authors:  Stephanie L Alberico; Young-Cho Kim; Tomas Lence; Nandakumar S Narayanan
Journal:  Neuroscience       Date:  2016-12-09       Impact factor: 3.590

4.  Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats.

Authors:  Michelle Healy-Stoffel; S Omar Ahmad; John A Stanford; Beth Levant
Journal:  Neurosci Lett       Date:  2013-05-02       Impact factor: 3.046

5.  Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.

Authors:  Nicole K Polinski; Terina N Martinez; Alexander Gorodinsky; Ralph Gareus; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Mali Cosden; Monika Kandebo; Robert E Drolet; Peter D Buckett; Weisong Shan; Yi Chen; Lee J Pellegrino; Gregory D Ellsworth; Leo B Dungan; Warren D Hirst; Sean W Clark; Kuldip D Dave
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

6.  The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models.

Authors:  Nicole K Polinski; Terina N Martinez; Sylvie Ramboz; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Lee J Pelligrino; Sean W Clark; Jacob N Marcus; Sean M Smith; Kuldip D Dave; Mark A Frasier
Journal:  Dis Model Mech       Date:  2022-05-25       Impact factor: 5.732

7.  High-frequency stimulation of the subthalamic nucleus counteracts cortical expression of major histocompatibility complex genes in a rat model of Parkinson's disease.

Authors:  Benjamin Grieb; Gerhard Engler; Andrew Sharott; Constantin von Nicolai; Thomas Streichert; Ismini Papageorgiou; Alexander Schulte; Manfred Westphal; Katrin Lamszus; Andreas K Engel; Christian K E Moll; Wolfgang Hamel
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

8.  Decomposition of abnormal free locomotor behavior in a rat model of Parkinson's disease.

Authors:  Benjamin Grieb; Constantin von Nicolai; Gerhard Engler; Andrew Sharott; Ismini Papageorgiou; Wolfgang Hamel; Andreas K Engel; Christian K Moll
Journal:  Front Syst Neurosci       Date:  2013-11-27

9.  A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research.

Authors:  Marco A S Baptista; Kuldip D Dave; Niketa P Sheth; Shehan N De Silva; Kirsten M Carlson; Yasmin N Aziz; Brian K Fiske; Todd B Sherer; Mark A Frasier
Journal:  Dis Model Mech       Date:  2013-09-12       Impact factor: 5.758

10.  Decreased argyrophilic nucleolar organiser region (AgNOR) expression in Purkinje cells: first signal of neuronal damage in sudden fetal and infant death.

Authors:  Anna M Lavezzi; Graziella Alfonsi; Teresa Pusiol; Luigi Matturri
Journal:  J Clin Pathol       Date:  2015-11-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.